Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.572
Bid: 1.57
Ask: 1.58
Change: -0.008 (-0.51%)
Spread: 0.01 (0.637%)
Open: 1.574
High: 1.582
Low: 1.57
Prev. Close: 1.58
CBKD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

1st Quarter Results - Consolidated Statements

13 May 2024 07:00

RNS Number : 0689O
Commercial Intnl Bank (Egypt) SAE
12 May 2024
 

Click on, or paste the following link into your web browser, to view the associated PDF document

http://www.rns-pdf.londonstockexchange.com/rns/0689O_1-2024-5-12.pdf

http://www.rns-pdf.londonstockexchange.com/rns/0689O_2-2024-5-12.pdf

Commercial International Bank (Egypt) S.A.E.

Consolidated Financial Statements 

March 31, 2024

Consolidated Statement of Financial Position as at March 31, 2024

 

Notes

Mar. 31, 2024

 

Dec. 31, 2023

EGP Thousands

 

EGP Thousands

Assets

 

 

 

Cash and balances at the central bank

9

36,731,091

 

71,887,821

Due from banks

10

292,721,033

 

231,085,244

Loans and advances to banks, net

12

1,140,170

 

822,448

Loans and advances to customers, net

13

270,496,805

 

234,985,936

Derivative financial instruments

 

1,677,011

 

1,105,148

Financial investments

 

 

 

- Financial Assets at Fair Value through P&L

14

974,297

 

-

- Financial Assets at Fair Value through OCI

14

249,660,996

 

233,125,234

- Financial Assets at Amortized cost

14

93,690,317

 

38,341,019

- Investments in associates

15

120,910

 

115,979

Non current assets held for sale

30.1

244

 

161

Other assets

16

25,011,464

 

18,972,786

Deferred tax assets

 

2,148,344

 

1,685,231

Property and equipment

17

2,774,970

 

2,739,092

Total assets

 

977,147,652

 

834,866,099

Liabilities and equity

 

 

 

Liabilities

 

 

 

Due to banks

18

5,529,064

 

12,458,003

Due to customers

19

796,080,537

 

677,237,479

Non current liabilities held for sale

30.2

1,297

 

873

Derivative financial instruments

 

602,480

 

140,934

Current income tax liabilities

 

5,445,769

 

9,395,534

Other liabilities

20

29,905,796

 

18,339,465

Issued debt instruments

21

4,699,516

 

3,073,349

Other loans

 

19,184,788

 

12,483,907

Other provisions

22

14,706,748

 

11,095,089

Total liabilities

 

876,155,995

 

744,224,633

Equity

 

 

 

Issued and paid up capital

 

30,195,010

 

30,195,010

Reserves

 

55,719,754

 

28,807,042

Reserve for employee stock ownership plan (ESOP)

 

1,786,010

 

1,486,010

Retained earnings *

 

13,130,675

 

29,993,331

Total equity and net profit for the period / year

 

100,831,449

 

90,481,393

Non Controlling Interest

 

160,208

 

160,073

Total minority interest, equity and net profit for the period/year

100,991,657

 

90,641,466

Total liabilities and equity

 

977,147,652

 

834,866,099

 

 

 

 

The accompanying notes are an integral part of these financial statements ..

 

( Limited Review report attached )

 

*

Including net profit for the current year

 

Hussein Abaza

 

Hisham Ezz Al-Arab

 

CEO & Managing Director

 

Chairman

 

 

 

 

 

 

 

 

Consolidated Income Statement for the year Ended March 31, 2024

 

 

 

Notes

 

Mar. 31, 2024

 

Mar. 31, 2023

 

EGP Thousands

 

EGP Thousands

 

 

 

 

Interest and similar income

36,652,802

 

19,823,554

 

Interest and similar expense

(17,852,691)

 

(8,939,377)

 

Net interest income

 

 

18,800,111

 

10,884,177

 

 

 

 

Fee and commission income

2,685,963

 

2,005,304

 

Fee and commission expense

(1,118,912)

 

(792,175)

 

Net fee and commission income

 

 

1,567,051

 

1,213,129

 

 

 

 

Dividend income

 

 

610

 

32,362

 

Net trading income

6

 

16,202,148

 

1,851,908

 

Profits (Losses) on financial investments 

14.1

 

224,271

 

70,920

 

Administrative expenses

 

 

(2,928,640)

 

(2,063,690)

 

Other operating income (expenses)

7

 

(14,975,056)

 

(2,040,922)

 

Goodwill amortization

-

 

(10,314)

 

Intangible assets amortization

-

 

(2,591)

 

Impairment release (charges) for credit losses

 

 

(1,421,114)

 

(944,829)

 

Bank's share in the profits / losses of associates

4,931

 

(14,871)

 

Profit before income tax

 

17,474,312

 

8,975,279

 

 

 

 

Income tax expense

29

 

(5,926,187)

 

(2,262,132)

 

Deferred tax assets (Liabilities)

29

376,765

 

(645,223)

 

Net profit from continued operations

 

11,924,890

 

6,067,924

 

 

 

 

Discontinued Operations

 

 

 

 

 

Net profit (loss) from discontinued operations

30.3

-

 

870

 

Net profit for the period

 

11,924,890

 

6,068,794

 

 

 

 

Non Controlling Interest

456

 

3,847

 

Bank's shareholders

 

11,924,434

 

6,064,947

 

 

 

 

Earnings per share

8

 

 

 

 

Basic

3.50

 

1.78

 

Diluted

3.46

 

1.76

 

 

 

 

Hussein Abaza

 

Hisham Ezz Al-Arab

 

CEO & Managing Director

 

Chairman

 

 

 

 

 

 

Condensed Consolidated Interim statement of Comprehensive Income for the period ended March 31, 2024

 

 

 

Mar. 31, 2024

 

Mar. 31, 2023

 

 

Net profit for the period

11,924,890

 

6,068,794

 

 

Transferred to RE from financial assets at fair value through comprehensive income

-

 

(1,895)

Change in fair value of Financial invesments measured at fair value through comprehensive income after tax

1,915,786

 

(8,522,293)

Cumulative foreign currencies translation differences

831,452

 

100,603

Effect of ECL on fair value of debt instruments measured at fair value through comprehensive income

744,813

 

208,752

Total comprehensive income for the period

 

15,416,941

 

(2,146,039)

As follows:

Bank's shareholders

15,416,485

 

(2,149,886)

Non Controlling Interest

456

 

3,847

Total comprehensive income for the period

 

15,416,941

 

(2,146,039)

 

 

 

 

Condensed Consolidated Interim Cash flows for the period ended March 31, 2024

 

 

 

Notes

Mar. 31, 2024

 

Mar. 31, 2023

 

EGP Thousands

 

EGP Thousands

 

 

 

 

Cash flow from operating activities

 

 

 

 

Profit before income tax from continued operations

17,474,312

 

8,975,279

 

Profit (loss) from discontinued operations

-

 

870

 

Adjustments to reconcile profits to net cash provided by operating activities

 

 

 

 

Fixed assets depreciation

17

261,427

 

228,065

 

Impairment Release/charge for credit losses (Loans and advances to customers and banks)

 

1,712,500

 

707,740

 

Other provisions Release/charge

22

41,587

 

464,311

 

Impairment Release/charge for credit losses (due from banks)

 

(646)

 

2,096

 

Impairment Release/charge for credit losses (financial investments)

 

(290,740)

 

234,993

 

Impairment Release/charge for other assets

(4,782)

 

-

 

Exchange revaluation differences for financial assets at fair value through OCI and AC

 

(17,328,576)

 

(6,033,831)

 

Goodwill amortization

 

-

 

10,314

 

Intangible assets amortization

 

-

 

2,591

 

Revaluation differences Impairment charge for Financial Assets at Fair value through OCI

1,130,412

 

-

 

Revaluation differences Impairment charge for Financial Assets at Amortized cost

95,225

 

-

 

Revaluation differences Impairment charge for due from banks

 

1,393

 

-

 

Utilization of other provisions

22

(297)

 

(345)

 

Other provisions no longer used

22

(4,220)

 

-

 

Exchange Revaluation differences of other provisions

22

3,574,589

 

1,169,894

 

Profits/losses from selling property and equipment

7

-

 

(118)

 

Profits/losses from selling financial investments at fair value through OCI

14.1

(224,271)

 

(70,920)

 

Share based payments

 

300,000

 

190,974

 

Bank's share in the profits / losses of associates

(4,931)

 

14,871

 

Operating profits before changes in operating assets and liabilities

6,732,982

 

5,896,784

 

 

 

 

 

 

Net decrease / increase in assets and liabilities

 

 

 

Due from banks

 

41,887,372

 

12,110,117

 

Financial assets at fair value through P&L

 

(974,297)

 

-

 

Derivative financial instruments

 

157,890

 

(359,998)

 

Loans and advances to banks and customers

12 - 13

(37,541,091)

 

(17,792,410)

 

Other assets

 

(5,893,831)

 

(96,139)

 

Non current assets held for sale

 

(244)

 

(220,335)

 

Due to banks

18

(6,928,939)

 

4,790,187

 

Due to customers

19

118,843,058

 

45,212,196

 

Current income tax obligations paid

 

(480,418)

 

(270,197)

 

Non current liabilities held for sale

1,297

 

890

 

Other liabilities

1,820,664

 

(354,332)

 

Net cash generated from (used in) operating activities

 

117,624,443

 

48,916,763

 

 

 

 

 

 

Cash flow from investing activities

 

 

 

Proceeds from sale of investments in associates

 

4,782

 

-

 

Payment for purchases of property, equipment and branches construction

(437,370)

 

(457,850)

 

Proceeds from selling property and equipment

-

 

118

 

Proceeds from redemption of financial assets at amortized cost

 

285,507

 

196,783

 

Payment for purchases of financial assets at amortized cost

(53,615,996)

 

(8,533,818)

 

Payment for purchases of financial assets at fair value through OCI

(26,592,698)

 

(32,339,905)

 

Proceeds from selling financial assets at fair value through OCI

26,222,450

 

46,767,421

 

Payment for investment in subsidiaries

-

 

(1,008,761)

 

Net cash generated from (used in) investing activities

(54,133,325)

 

4,623,988

 

 

 

 

 

 

 

 

 

Condensed Consolidated Interim Cash flows for the period ended March 31, 2024 (Cont.)

 

 

 

Mar. 31, 2024

 

Mar. 31, 2023

 

EGP Thousands

 

EGP Thousands

 

 

 

 

Cash flow from financing activities

 

 

 

 

Other loans

 

6,700,881

 

1,607,404

 

Dividends paid

(5,078,792)

 

(1,988,585)

 

Issued debt instruments

1,626,167

 

612,624

 

Capital increase

-

 

165,429

 

Net cash generated from (used in) financing activities

 

3,248,256

 

396,872

 

 

 

 

Net (decrease) increase in cash and cash equivalent during the period

66,739,374

 

53,937,623

 

Beginning balance of cash and cash equivalent

234,317,913

 

92,969,526

 

Cash and cash equivalent at the end of the period

301,057,287

 

146,907,149

 

 

 

 

 

 

:Cash and cash equivalent comprise

 

 

 

Cash and balances at the central bank

 

36,731,091

 

52,462,528

 

Due from banks

 

292,723,938

 

170,733,811

 

Treasury bills and other governmental notes

 

119,754,167

 

68,681,151

 

Obligatory reserve balance with CBE

 

(19,531,282)

 

(46,005,523)

 

Due from banks with maturity more than three months

 

(8,740,302)

 

(29,664,721)

 

Treasury bills and other governmental notes with maturity more than three months

(119,880,325)

 

(69,300,097)

 

Total cash and cash equivalent

301,057,287

 

146,907,149

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Consolidated Interim statement of changes in shareholders' equity

 

Mar. 31, 2023

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Reserve for transactions under common control

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Cumulative foreign currencies translation differences

Total Shareholders Equity

Non Controlling Interest

Total

Beginning balance

29,825,134

3,963,946

27,096,858

1,550,906

8,183

18,947

(13,188,818)

11,981

16,393,841

1,895,435

181,324

67,757,737

580,431

68,338,168

Capital increase

165,429

-

-

-

-

-

-

-

-

-

-

165,429

-

165,429

Reserve for transactions under common control

-

-

-

-

(679,155)

-

-

-

-

-

-

(679,155)

-

(679,155)

Transferred to reserves

-

806,408

11,998,639

-

-

2,208

-

-

(12,388,223)

(419,032)

-

-

-

-

Dividends paid

-

-

-

-

-

-

-

-

(3,738,888)

-

-

(3,738,888)

(23,982)

(3,762,870)

Net profit for the period

-

-

-

-

-

-

-

-

6,064,947

-

-

6,064,947

3,847

6,068,794

Change in non controlling interest from acquisition of subsidiaries

-

-

-

-

-

-

-

-

-

-

-

-

(536,867)

(536,867)

 

Transferred to RE from financial assets at fair value through OCI

-

-

-

-

-

-

(1,895)

-

1,895

-

-

-

-

-

 

Net unrealized gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

-

(8,522,293)

-

-

-

-

(8,522,293)

-

(8,522,293)

 

Transferred (from) to banking risk reserve

-

-

-

-

-

-

-

3,249

(3,249)

-

-

-

-

-

 

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

-

208,752

-

-

-

-

208,752

-

208,752

 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

-

190,974

-

190,974

-

190,974

Cumulative foreign currencies translation differences

-

-

-

-

-

-

-

-

-

-

100,603

100,603

99,192

199,795

Balance at 31 March 2023

29,990,563

4,770,354

39,095,497

1,550,906

(670,972)

21,155

(21,504,254)

15,230

6,330,323

1,667,377

281,927

61,548,106

122,621

61,670,727

 

 

 

 

 

 

 

 

Mar. 31, 2024

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Reserve for transactions under common control

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Cumulative foreign currencies translation differences

Total Shareholders Equity

Non Controlling Interest

Total

Beginning balance

30,195,010

4,770,354

39,840,707

1,550,906

(670,972)

21,155

(16,868,691)

15,230

29,993,331

1,486,010

148,353

90,481,393

160,073

90,641,466

 

Capital increase

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Transferred to reserves

-

1,438,320

21,958,960

-

-

1,663

-

-

(23,398,943)

-

-

-

-

-

Dividends paid

-

-

-

-

-

-

-

-

(5,366,429)

-

-

(5,366,429)

-

(5,366,429)

Net profit for the period

-

-

-

-

-

-

-

-

11,924,434

-

-

11,924,434

456

11,924,890

Transferred to RE from financial assets at fair value through OCI

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in non controlling interest from acquisition of subsidiaries

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Transferred from RE to banking risk reserve

-

-

-

-

-

-

-

19,024

(19,024)

-

-

-

-

-

Net unrealised gain/(loss) on financial assets at fair value through OCI after tax

-

-

-

-

-

-

1,915,786

-

-

-

-

1,915,786

-

1,915,786

Transferred (from) to banking risk reserve

-

-

-

-

-

-

-

2,694

(2,694)

-

-

-

-

-

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

-

744,813

-

-

-

-

744,813

-

744,813

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

-

300,000

-

300,000

-

300,000

Cumulative foreign currencies translation differences

-

-

-

-

-

-

-

-

-

-

831,452

831,452

(321)

831,131

 Ending balance

30,195,010

6,208,674

61,799,667

1,550,906

(670,972)

22,818

(14,208,092)

36,948

13,130,675

1,786,010

979,805

100,831,449

160,208

100,991,657

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFDLLFFZELBBBQ
Date   Source Headline
5th Nov 20197:00 amRNSCIB 3Q 2019 Consolidated Financial Results
5th Nov 20197:00 amRNSCIB Separate 3rd Quarter Results
5th Nov 20197:00 amRNSCIB 3Q 2019 Earnings Release
9th Oct 20197:00 amRNSChanges in CIB's Board of Directors
9th Jul 20197:00 amRNSHalf-year Report
9th Jul 20197:00 amRNSCIB First Half 2019 Separate Financial Results
9th Jul 20197:00 amRNSCIB First Half 2019 Consolidated Financial Results
12th Jun 20193:04 pmRNSResolutions of CIB EGM 12 June 2019
16th May 20191:12 pmRNSItems to be discussed in CIB's June 12th EGM
16th May 20191:08 pmRNSInvitation to CIB's Extraordinary GAM
7th May 20197:00 amRNSCIB 1st Separate Quarter Results
7th May 20197:00 amRNSCIB Q1' 2019 Earnings Release
7th May 20197:00 amRNSCIB 1st Consolidated Quarter Results
18th Apr 20192:10 pmRNSRelease concerning CIB's Rep Office in Ethiopia
8th Apr 20197:00 amRNSCIB's 2018 IFRS Consolidated Financial Statements
14th Mar 20191:43 pmRNSCIB postpones the Extraordinary General Meeting
13th Mar 20191:16 pmRNSNotice of CIB's EGM (second meeting) on March 20th
11th Mar 20197:42 amRNSInvitation to CIB's EGA (Second) Meeting
11th Mar 20197:00 amRNSCIB Ordinary General Assembly Meeting Resolutions
7th Feb 20197:00 amRNSNotice of Extraordinary General Assembly Meeting
5th Feb 20197:00 amRNSCIB FY 2018 Earnings Release
5th Feb 20197:00 amRNSCIB FY 2018 Separate Financials Results
5th Feb 20197:00 amRNSCIB FY 2018 Consolidated Financials Results
4th Dec 20182:52 pmRNSClarification regarding proposed tax law amendment
8th Nov 20187:00 amRNS3rd Quarter Separate Results
8th Nov 20187:00 amRNS3rd Quarter Consolidated Results
8th Nov 20187:00 amRNS3rd Quarter Earnings Release
2nd Aug 201810:43 amRNSCIB 1H 2018 Separate Financial Results
2nd Aug 201810:40 amRNSCIB 1H 2018 Consolidated Financial Results
2nd Aug 20187:00 amRNSCIB 1H 2018 Earnings Release
2nd Aug 20187:00 amRNSCIB 1H 2018 Consolidated Financial Results
2nd Aug 20187:00 amRNSCIB 1H 2018 Separate Financial Results
16th Jul 20187:56 amRNSStatement by CIB- Update
12th Jul 20189:07 amRNSManagement Statement
9th May 20187:00 amRNS1st Quarter Earnings Release
9th May 20187:00 amRNS1st Quarter Separate Results
9th May 20187:00 amRNS1st Quarter Consolidated Results
5th Apr 20182:59 pmRNSUpdated Insider List
3rd Apr 20187:00 amRNSAnnual Financial Report
5th Mar 20187:00 amRNSSummary of GAM Resolutions
9th Feb 20187:00 amRNSInvitation to CIB's Ordinary General Assembly
1st Feb 20187:00 amRNSAnnual Financial Report
1st Feb 20187:00 amRNSCIB's Yer-end Seperate Financial Statements
1st Feb 20187:00 amRNSCIB's year-end 2017 Earnings Release
7th Dec 20177:00 amRNSCIB appoints two new non-executives to the Board
28th Nov 20177:24 amRNSIFC to provide CIB with $100 mn subordinated loan
14th Nov 20178:26 amRNSEBRD to provide CIB with a sub loan of USD 100 M
9th Nov 20177:00 amRNS3rd Quarter Separate Results
9th Nov 20177:00 amRNS3rd Quarter Results Earnings Release
9th Nov 20177:00 amRNS3rd Quarter Consolidated Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.